glp-1 heart failure medications are not just for weight loss — they are the most important drug class of our lifetime. 🫀 A 2025 meta-analysis of 99,599 patients confirmed: ✓ 20% reduction in major Cardiovascular benefits of glucagon-like peptide-1

A high-fat diet has been shown to reduce gram-positive Bifidobacteria levels in the digestive system while increasing the amount of intestinal microbes that hold LPS, both of which contribute to obesity, the primary risk factor for CVD (39)

Il contient de la vitamine C et de l'acide kojique

It helps improve blood sugar, metabolism, and cardiovascular health, and it has anti-inflammatory properties that can affect biomarkers

Medication Is a Tool, Not the Entire Maintenance Plan GLP-1 medications can be powerful tools, but they should not replace the foundations of long-term metabolic care

Our experience suggests that while a systemic dose will eventually reach the ankle, a localized dose may create a much higher concentration gradient in the target tissue for a more potent and immediate effect